Aug 8 (Reuters) - Achieve Life Sciences Inc ACHV.O :
* ACHIEVE REPORTS FINANCIAL RESULTS FOR SECOND QUARTER 2019 AND PROVIDES CYTISINICLINE CLINICAL DEVELOPMENT UPDATE
* QTRLY LOSS PER SHARE $0.50
* Q2 EARNINGS PER SHARE VIEW $-0.56 -- REFINITIV IBES DATA